This is the ideal opportunity to meet with some of the biggest names in hepatology in a face to face interactive setting!
Invited experts will provide answers to challenging questions from Thursday 12 to Sunday 15 April 2018 (hall 7.3) during 16 informal workshops.
|08:30-09:20||Management of autoimmune hepatitis||Chairs: Olivier Chazouillères, Michael Manns|
|09:30-10:20||Non invasive tests in liver diseases||Chairs: Laurent Castera, Massimo Pinzani|
|10:30-11:20||Management of HCV infection in patients with HCC||Chairs: Jordi Bruix, Antonio Craxì|
|12:00-12:50||Hepatorenal syndrome||Chairs: Paolo Angeli, Pere Gines|
|16:00-16:50||Antibiotic stewardship in cirrhosis||Chairs: Raffaele Bruno, Valentin Fuhrmann|
|17:00-17:50||Achieving alcohol abstinence||Chairs: Antonio Gual, Maja Thiele|
|11:30-12:20||Difficult cases of HCV therapy: is there any?||Chairs: Xavier Forns, Jean-Michel Pawlotsky|
|14:00-14:50||Prevention of decompensation in cirrhosis||Chairs: Jaime Bosch, Emmanuel Tsotschatzis|
|16:00-16:50||Portal vein thrombosis||Chairs: Andrea de Gottardi, Sarwa Darwish Murad|
|17:00-17:50||Alpha-1-Antitrypin deficiency||Chairs: Ron Sokol, Pavel Strnad|
|08:00-08:50||Hepatitis B: Should we treat immuntolerant patients?||Chairs: Patrick Kennedy, Anna Lok|
|09:00-09:50||Hepatitis B: When to stop NUC therapy?||Chairs: Maria Buti, George Papatheodoridis|
|12:30-13:20||Cirrhosis after HCV cure||Chairs: Roberta D’Ambrosio, Stefan Zeuzem|
|14:00-14:50||Management of patients with chronic hepatitis E||Chairs: Harry Dalton, Harry Dalton|